Recently appointed Chairman of the Spacecode Healthcare Board of Directors, Philippe is the Special Advisor to the United Nations Secretary-General on Innovative Finance for Development, with the rank of Under Secretary-General. He served as Special Advisor to the “High-Level Taskforce on Innovative International Financing for Health Systems”. In 2006, he was the founding president of UNITAID, a multilateral South-North organization and a global health partnership (based at the World Health Organization in Geneva, Switzerland). He has held several ministerial positions in his native France, including Minister of Health (1993-1995), Minister of Culture and Communication (1995-1997), Minister for Solidarity, Health and Family (2004-2005) and Minister of Foreign Affairs (2005-2007). Prior to embracing policy initiatives, Philippe was a practicing cardiologist and Professor of Public Health at Toulouse University in France.
Pavlo Protopapa is the Chairman & CEO of Spacecode Group. Prior to founding Spacecode Group in 2005, Pavlo was the Chief Financial Officer of the Steinmetz Diamond Group (1998-2012), one the world’s largest diamond companies, and represented it on the board of Sotheby’s Diamonds Holdings. Pavlo serves as a non-executive director of Socure Inc., the industry leader in real-time online identity verification solutions, and MidatechPharma PLC, a global leader in the design, synthesis and manufacture of nanomedicines. Pavlo studied economics, accounting and commercial law at the University of the Witwatersrand in Johannesburg, South Africa, and completed his articles at KPMG in 1993.
Dr. Craig Richard Cook
Craig Cook has more than 15 years of international experience in the pharma, biomedical and high technology sectors including roles across a range of therapeutic areas, such as neurology, inflammatory, immunology, and endocrine, covering both drug development and medical affairs. He has established and led several healthcare initiatives, and held increasingly senior appointments at Johnson & Johnson, Eli Lilly, Novartis Pharma, and Serono Biotech.
Craig co-founded Spacecode with Pavlo Protopapa and served as CEO until 2013. He is a qualified physician, has a BSc in Pharmacology, Diploma in Anaesthesiology, and an MBA from the London Business School. He joined Midatech Pharma in 2014 and serves as Chief Executive Officer and Board Director as of June 1, 2018.
From running an emergency medical & trauma unit in Gugulethu at 22 years of age, Michael has built a career in Med Tech and Biotech by building and leading high-performance teams in large corporates, start-ups and now growth stage companies. Since 2015, Michael has served as President and CEO of Spectrum Dynamics, a global leader in nuclear cardiology selling capital equipment, services and software where he has overseen development from breakeven and $15M to $40M in sales. Prior to this, in 2010, he founded Avance Medical sarl and has held senior management and leadership roles at Cardinal Health, (then Carefusion now owned by Becton Dickinson), Invitrogen Life Technologies, and Johnson & Johnson. Michael has a BSc and MBA, as well as multiple advanced life support certifications.